A Trial to Study the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Dermatosis Papulosa Nigra (DPN)

Conditions: Dermatosis Papulosa Nigra Interventions: Drug: SM-020 gel 1.0% Sponsors: DermBiont, Inc. Not yet recruiting

Source: ClinicalTrials.gov - October 25, 2023 Category: Research Source Type: clinical trials